Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Electrum Advances AMT Geophysical Survey Identifying Additional Drill Targets (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Petros Pharmaceuticals Inc (PK) PTPI

Healthcare Drug Manufacturers - Specialty & Generic Medical Devices
Petros Pharmaceuticals, Inc., a healthcare technology company, focuses on developing and licensing proprietary SaaS platform and Software as a medical device web application designed to assist pharmaceutical companies. The company is based in New York, New York.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (PINL:PTPI)

Petros Pharmaceuticals Announces Deconsolidation of Metuchen Pharmaceuticals Subsidiary, Strengthening its Balance Sheet and Improving the Company's Equity Position

ACCESS Newswire June 25, 2025

Petros Pharmaceuticals Announces Transition from NASDAQ to OTC Markets

ACCESS Newswire May 21, 2025

Petros Pharmaceuticals Partners with Innolitics, a Leading Software-as-a-Medical-Device Developer

ACCESS Newswire May 20, 2025

Petros Pharmaceuticals Strengthens Partnership with Market Leading Big Data Provider Implementing Key Enhancements to its AI Platform

ACCESS Newswire May 6, 2025

Petros Pharmaceuticals Developing First-in-Industry SaaS Platform Utilizing AI and Electronic Health Records Intended to Facilitate Rx-OTC Switches

ACCESS Newswire May 1, 2025

Petros Proprietary Technology Platform Aligns with April 15, 2025 President Trump Executive Order Advancing Rx-to-OTC Reclassification Reforms

ACCESS Newswire April 29, 2025

Petros Pharmaceuticals to Partner with Renowned Big Data Provider to Enable Rx-to-OTC Switch Across Multiple Indications

ACCESS Newswire March 20, 2025

Petros Pharmaceuticals' Proprietary Technology Demonstrates Positive Data in Pivotal Study

ACCESS Newswire February 25, 2025

Petros Pharmaceuticals Announces Pricing of $9.6 Million Public Offering of Common Stock and Warrants

ACCESS Newswire February 18, 2025
View More News ››

Opinion & Analysis (PINL:PTPI)

No current opinion is available.
View More Opinion ››

Bullboard Posts (PINL:PTPI)

PTPI.... Another one bites the dust..delisted to OTC

  Petros Pharmaceuticals Announces Transition from NASDAQ to OTC Markets   2025-05-21 06:03 ET - News Release   ...
Iseneschal - May 21, 2025

PTPI.... Trading big volume in PM...Price action Meh !

I just don't trust this train wreck Recent RS...but It obviously wasn't big enough to have it tradong above $1 Seems as though...
Iseneschal - May 15, 2025

Petros Pharmaceuticals (PTPI): Navigating the Path to Prescr

Interesting play on the ED med market. PTPI's OTC transition for STENDRA looks promising but cash is tight. Q3 numbers aren't...
MikeTester - January 24, 2025

Petros Pharmaceuticals, Inc. (NASDAQ:PTPI): Navigating the E

http://beyondspx.com/2024/08/01/petros-pharmaceuticals-inc-nasdaqptpi-navigating-the-evolving-ed-landscape-with-innovative-strategies/
MikeTester - August 1, 2024

PTPI ....Nr and vol /price pop

on watch at $1.60
Iseneschal - March 19, 2024

PTPI ....needs a break of $3.50 with volume

No position
Iseneschal - July 12, 2023
View more Bullboard ››

LaFleur Minerals Inc.

LaFleur Minerals Inc.

LaFleur Minerals Inc. explores for lithium and gold deposits in Canada. The company holds interest in the Swanson Gold ...
View More »

Podcasts